High Return On Equity, Low Debt

Results

37

9 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

37 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
600519
CN„1,292.300.06%-10.6%CN„1.6tCN„1,695.0819.87.1%4.0%Food, Beverage & Tobacco
601899
New
CN„34.570.9%53.5%CN„899.4bCN„47.9913.513.4%1.2%Materials
300394
CN„267.16-3.3%107.8%CN„291.4bCN„317.25125.547.2%0.2%Tech
002379
CN„18.706.3%7.6%CN„243.7bCN„29.009.912.0%1.3%Materials
301666
New
CN„469.2012.2%n/aCN„204.7bn/a169.6n/an/aTech
300033
CN„233.225.9%-19.8%CN„175.5bCN„267.5148.014.4%1.6%Diversified Financials
301377
New
CN„416.971.2%441.0%CN„175.4bCN„611.50185.567.5%0.5%Capital Goods
000408
CN„78.832.2%55.5%CN„123.3bn/a21.726.4%3.8%Materials
605117
CN„96.783.3%117.9%CN„123.2bCN„137.6428.223.8%2.1%Capital Goods
688183
CN„121.6916.6%52.9%CN„101.9bCN„159.0049.634.2%0.7%Tech
300475
CN„165.335.2%298.5%CN„77.6bCN„240.0041.833.9%0.07%Tech
600066
CN„29.91-0.5%9.4%CN„66.2bCN„39.6312.111.5%8.4%Capital Goods
688766
New
CN„429.89-10.5%436.2%CN„63.6bn/a64.1n/a0.03%Semiconductors
688578
CN„115.05-4.7%1.5%CN„51.8bn/a19.313.6%1.0%Pharmaceuticals & Biotech
300628
New
CN„39.87-6.0%5.8%CN„50.5bCN„49.4517.514.3%4.5%Tech
688826
New
CN„1,016.217.3%n/aCN„40.6bn/a244.2n/an/aCapital Goods
603699
CN„51.76-4.4%59.5%CN„40.1bCN„69.2023.619.2%3.1%Capital Goods
301696
CN„98.28-0.3%n/aCN„39.3bn/a74.7n/a0.5%Capital Goods
688336
CN„43.61-10.3%29.8%CN„39.1bCN„60.9412.7-50.4%0.8%Pharmaceuticals & Biotech
688266
CN„119.70-13.5%18.3%CN„31.7bCN„139.0557.6-15.6%n/aPharmaceuticals & Biotech
600961
CN„27.611.9%103.3%CN„29.6bCN„45.0011.911.1%n/aMaterials
603444
CN„388.36-1.4%-15.8%CN„27.9bCN„468.5413.74.7%5.0%Media
300456
New
CN„37.0617.5%49.9%CN„27.1bn/a6.5n/a1.0%Tech
688278
New
CN„59.05-9.1%-28.6%CN„24.1bCN„80.0022.324.6%1.1%Pharmaceuticals & Biotech
Page 1 of 2